Spark Therapeutics, Inc.
Edit

Spark Therapeutics, Inc.

http://sparktx.com/
Last activity: 24.04.2024
Categories: BioTechCareHealthTechITJobLearnPlatformProduct
At Spark Therapeutics, we don’t follow footsteps. We create the path. We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is seemingly impossible to others, but not to us: Challenge the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now. Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm. Join us on a journey through uncharted territory – seeking to bring gene therapy for genetic diseases to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine for those with inherited diseases. Spark is a member of the Roche Group. Know that working at Spark Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world free of genetic disease. To learn more about Spark and our open positions, visit www.sparktx.com. You can also find us on Twitter at @Spark_tx.
Followers
5.5K
Website visits
13K /mo.
Mentions
64
Location: United States, Pennsylvania, Philadelphia
Employees: 501-1000
Total raised: $73M
Founded date: 2013

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
27.05.2014Series B$73M-

Mentions in press and media 64

DateTitleDescriptionSource
24.04.2024Prevent Blindness Declares May as First-ever Inherited Retin...Prevent Blindness declares the month of May as "Inherited Retinal Disease Genetic Testing Aware...prweb.com/...
17.04.2024World Hemophilia Day 2024"Equitable access for all: rec...MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community ...en.prnasia...
09.05.2023Prevent Blindness Declares Fourth Annual Inherited Retinal D...Prevent Blindness declares May 15-21, 2023, as the 4th annual “Inherited Retinal Disease (IRD) Genet...prweb.com/...
11.05.2022Prevent Blindness Declares Third Annual Inherited Retinal Di...To help save sight, Prevent Blindness declares May 16-22 as the Third Annual Inherited Retinal Disea...prweb.com/...
10.05.2022The POWER of Professional Women Honors Allies for Women in B...Executive leaders from Day & Zimmermann and Santander Bank, N.A. will be recognized for their ad...einpresswi...
12.10.2021Spark Therapeutics and CombiGene Enter into Exclusive, Globa...PHILADELPHIA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX...globenewsw...
14.05.2021Prevent Blindness Declares Second Annual Inherited Retinal D...Prevent Blindness declares May 16-22, 2021, as it's second annual “Inherited Retinal Disease (IRD) G...prweb.com/...
30.11.2020Navigating the challenge of covering breakthrough therapies ...Our virtual MedCity INVEST Precision Medicine conference, December 9-11, will highlight aspects of p...medcitynew...
24.11.2020Mark your calendars for our virtual INVEST Precision Medicin...What Does the Diagnostics Landscape Look Like? Diagnostics is joined at the hip with precision medic...medcitynew...
16.05.2019Installment payments could be used across gene therapy space...“Certainly, we are continuously optimistic, but we would like to see the pace of policy changes we w...medcitynew...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In